Sheng GX, Zhang YJ, Shang T. Synergistic inhibition of colorectal cancer progression by silencing Aurora A and the targeting protein for Xklp2. World J Gastrointest Surg 2025; 17(1): 97148 [PMID: 39872788 DOI: 10.4240/wjgs.v17.i1.97148]
Corresponding Author of This Article
Tao Shang, Department of Colorectal Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), No. 54 Youdian Road, Shangcheng District, Hangzhou 310006, Zhejiang Province, China. shangtaomail@163.com
Research Domain of This Article
Cell Biology
Article-Type of This Article
Basic Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Jan 27, 2025; 17(1): 97148 Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.97148
Table 1 Basic information on the gene expression omnibus dataset included in the study
GEO
Group
n
Stage
Tissue
Gene number
GSE21510
CN
12
0-2
Normal
715
CRC
8
1-2b
Cancer
GSE25071
CN
3
0
Colon
788
CRC
7
I-II
Primary tumor
GSE32323
CN
9
1-2
Normal
446
CRC
9
1-2b
Cancer
Table 2 Sequence information of the primers for quantitative real time-polymerase chain reaction
Gene
Forward primer
Reverse primer
Human AURKA
5’-TGGGTGGTCAGTACATGCTC-3’
5’-TGCATCCGACCTTCAATCATTTC-3’
Human TPX2
5’-ACTTCCGCACAGATGAGCG-3’
5’-GGATGCTTTCGTAGTTCAGATGT-3’
Human β-actin
5’-GATGACCCAGATCATGTTTGAG-3’
5’-TAATGTCACGCACGATTTCC-3’
Table 3 Antibody information
Antibody
Manufacturer
No.
Dilution ratio
AURKA antibody
Affinity
BF0123
1:2000
TPX2 antibody
Abcam
ab264124
1:5000
Cyclin B1 antibody
Affinity
AF6168
1:2000
CDK1 antibody
Abcam
ab133327
1:15000
CDK2 antibody
Affinity
AF6237
1:2000
Bax antibody
Abcam
ab182733
1:2000
Bcl-2 antibody
Affinity
AF6139
1:2000
Caspase-3 antibody
Proteintech
19677-1-AP
1:10000
p53 antibody
Affinity
AF0879
1:2000
N-cadherin antibody
Affinity
AF4039
1:2000
E-cadherin antibody
Proteintech
20874-1-AP
1:5000
Vimentin antibody
Zenbio
R22775
1:1000
p-AURKA antibody
Affinity
AF3011
1:2000
β-actin antibody
Proteintech
81115-1-RR
1:20000
Anti-rabbit IgG, HRP-linked antibody
CST
7074
1:10000
Table 4 Potential target proteins and their degrees in the relative overexpressed gene set analyzed by Cytoscape
No.
Node
Degrees
1
CCNB1
14
2
CDK1
14
3
CDKN3
13
4
UBE2C
13
5
ANLN
12
6
AURKA
12
7
CENPA
12
8
CKS2
12
9
TPX2
12
10
CENPN
11
11
TRIP13
11
12
CKAP2
10
13
CXCL10
10
Table 5 The search tool for the retrieval of interacting genes analysis results of protein-protein interaction forces (TOP 7, score = 0.999)
Node 1
Node 2
Co-expression
Experimentally determined interaction
Database annotated
Combined score
CCNB1
CDK1
0.895
0.999
0.9
0.999
AURKA
TPX2
0.846
0.988
0.9
0.999
CXCL10
CXCL11
0.824
0.994
0.9
0.999
CDK1
CKS2
0.689
0.992
0
0.999
CCNB1
CKS2
0.688
0.978
0
0.999
CENPA
CENPN
0.407
0.955
0.5
0.999
CXCL11
CXCL2
0.107
0.994
0.5
0.999
Citation: Sheng GX, Zhang YJ, Shang T. Synergistic inhibition of colorectal cancer progression by silencing Aurora A and the targeting protein for Xklp2. World J Gastrointest Surg 2025; 17(1): 97148